Replica aims to use machine learning and synthetic simulations to make urban planning more efficient and inclusive. Translating "real" data into "synthetic" data offers promise for addressing the privacy concerns critics have.
Data
John Deere: Planting the Seeds of Technology and Harvesting Profits
John Deere is on the cutting edge of AI, ML, and computer vision applications in agriculture, and well-positioned to reap the benefits of the digital innovations sprouting in Silicon Valley.
Nuance: Expanding Human Intelligence in Healthcare
Nuance is leveraging AI and data analytics to create time-saving speech recognition documentation software for medical professionals, addressing a dramatic pain point in healthcare.
Robo-Banking: Artificial Intelligence at JPMorgan Chase
JPMorgan Chase is leading the way in AI-enabled banking with a comprehensive strategy that spans across business lines and functions to create value for the company, its clients, and the industry as a whole.
Spotify’s winning data strategy may be hampered by operational challenges
Spotify is leveraging loads of data to enhance the music listening experience
Nuance: an AI solution physicians love
Nuance has developed AI solutions that physicians love, captured a significant portion of the U.S. health care market, and is primed to be a major player going forward in the clinical recommendation and diagnostics space.
182-year-old P&G enters Big Data with Start-Up Pampers and Smart Diapers
P&G creates Start-Up Pampers and takes to the 2020 Consumer Electronics Show with the Lumi care connected system. A bundle of smart diapers, baby monitors, and a consumer facing app aims to combine parental insight with real time activity tracking to help first time parents ascend the steep learning curve that comes with caring for a new born baby and feeling confident while doing so.
Ment.IO Data analytics for team-based decision making
Collaborate remotely without feeling remote
AstraZeneca: AI in Drug Discovery & Development
Currently, it takes a staggering 10-15 years and costs $2.6 billion to develop a new drug, and an astonishing proportion of this is lost in the 90% of candidates that fail. AstraZeneca is one of the world’s largest Pharmaceutical companies and is incorporating AI in every step of the R&D chain from drug discovery to launch to make this process safer, quicker and less costly.
Affectiva: building AI that reads human emotions
As the amount of data we collect increases, companies are leveraging advanced analytics to drive insights also from the most unusual sources of data, including people facial expressions or speech. In fact, an interesting application of artificial intelligence (AI) and […]